BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31138494)

  • 1. Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?
    La Marca A; Capuzzo M
    Reprod Biomed Online; 2019 Aug; 39(2):321-331. PubMed ID: 31138494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF.
    Massin N
    Hum Reprod Update; 2017 Mar; 23(2):211-220. PubMed ID: 28062551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medroxyprogesteron acetate use to block LH surge in oocyte donor stimulation].
    Crha I; Ventruba P; Filipinská E; Dziakova M; Žáková J; Ješeta M; Lousová E; Papíková Z
    Ceska Gynekol; 2018; 83(1):11-16. PubMed ID: 29510633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial.
    Wang Y; Kuang Y; Chen Q; Cai R
    Trials; 2018 Aug; 19(1):455. PubMed ID: 30134964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses.
    Ata B; Capuzzo M; Turkgeldi E; Yildiz S; La Marca A
    Hum Reprod Update; 2021 Jan; 27(1):48-66. PubMed ID: 33016316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF/ICSI compared to a GnRH antagonist protocol: A retrospective study.
    Huang P; Tang M; Qin A
    J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):99-102. PubMed ID: 30321608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval.
    Kao TC; Hsieh YC; Yang IJ; Wu MY; Chen MJ; Yang JH; Chen SU
    J Formos Med Assoc; 2023 Jan; 122(1):29-35. PubMed ID: 36123235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.
    Dong J; Wang Y; Chai WR; Hong QQ; Wang NL; Sun LH; Long H; Wang L; Tian H; Lyu QF; Lu XF; Chen QJ; Kuang YP
    BJOG; 2017 Jun; 124(7):1048-1055. PubMed ID: 28276192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome.
    Ye H; Tian H; He W; Lyu Q; Kuang Y; Chen Q; Sun L
    Reprod Biol Endocrinol; 2018 May; 16(1):53. PubMed ID: 29807533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation.
    La Marca A; Capuzzo M; Sacchi S; Imbrogno MG; Spinella F; Varricchio MT; Minasi MG; Greco P; Fiorentino F; Greco E
    Hum Reprod; 2020 Jun; 35(6):1325-1331. PubMed ID: 32395749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.
    Chen Q; Wang Y; Sun L; Zhang S; Chai W; Hong Q; Long H; Wang L; Lyu Q; Kuang Y
    Reprod Biol Endocrinol; 2017 Sep; 15(1):71. PubMed ID: 28870217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis.
    Alexandru P; Cekic SG; Yildiz S; Turkgeldi E; Ata B
    Reprod Biomed Online; 2020 Jun; 40(6):894-903. PubMed ID: 32327297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does LH suppression by progesterone-primed ovarian stimulation compared with GnRH antagonist affect live birth rate among oocyte recipients?
    Martínez F; Clúa E; García S; Coroleu B; Polyzos NP; Barri PN
    Reprod Biomed Online; 2020 May; 40(5):661-667. PubMed ID: 32268981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
    Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
    Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology.
    Iwami N; Kawamata M; Ozawa N; Yamamoto T; Watanabe E; Moriwaka O; Kamiya H
    Arch Gynecol Obstet; 2018 Sep; 298(3):663-671. PubMed ID: 30069600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.